Lifeward Ltd. shares fall 1.34% premarket after Medicare ruling on ReWalk Exoskeleton.

Lifeward Ltd. declined 1.34% in premarket trading, following the news that an Administrative Law Judge has ruled in favor of an appeal by a Medicare beneficiary, determining that the ReWalk Personal Exoskeleton shall be covered and reimbursed by Medicare. This decision establishes the medical necessity of the ReWalk Exoskeleton for enabling paralyzed individuals to stand and walk in everyday environments.